Woodside Energy Flags Lower 2026 Production Outlook Despite Strong Q4 Revenue Beat 
ASML’s EUV Monopoly Powers the Global AI Chip Boom 
BYD and Exxon Mobil Strengthen Hybrid Technology Partnership 
Anthropic Raises 2026 Revenue Outlook by 20% but Delays Path to Profitability 
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company 
Hyundai Motor Shares Slide After Trump Signals Higher U.S. Tariffs on South Korean Goods 
Microsoft Wins Approval to Build 15 New Data Centers in Wisconsin 
Micron to Expand Memory Chip Manufacturing Capacity in Singapore Amid Global Shortage 
Google Halts UK YouTube TV Measurement Service After Legal Action 
Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday 
Ford and GM Near Financing Deal to Support First Brands Group During Bankruptcy 
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors 
Puma’s Historic Rivalry With Adidas Enters a New Era as Anta Deal Signals Turnaround Push 
The Maire - EuroChem Case: Three Lessons for Global Business 
Zijin Mining Shares Hit Record High on $4 Billion Allied Gold Acquisition 
SoftBank Shares Surge as It Eyes Up to $30 Billion New Investment in OpenAI 
IRVINE, Calif., May 18, 2017 -- Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Amyris, Inc. (“Amyris” or the “Company”) (Nasdaq:AMRS). Investors who purchased or otherwise acquired shares between March 2, 2017 and April 17, 2017 inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the June 19, 2017 lead plaintiff motion deadline.
If you purchased shares of Amyris during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
According to the Complaint, throughout the Class Period, Amyris made false and/or misleading statements and/or failed to disclose: that in the first quarter of 2017, the Company made a decision to take an equity stake in one of Blue California’s affiliates that focused on the sweetener market instead of cash payment under the license agreement; that due to this decision Amyris would be unable to recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this information came out, Amyris’ share price dropped materially, which allegedly caused investors harm.
If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at [email protected].
This press release may constitute Attorney Advertising in certain jurisdictions.
Contact Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 [email protected]
